Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Alere San Diego, Inc.

US

Last updated September 17, 2026

About

With point-of-care diagnostics, everyday moments can lead to better global health outcomes. Abbott is committed to developing point-of-care diagnostic tests that are able to provide invaluable answers to doctors, clinicians and nurses at just the right time and where they are most needed.

Translated from the manufacturer's own website. Source

Information

Country
US
Address
829 Towne Center Dr, Pomona, CA, 91767
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2020952
DUNS Number
—

Catalogue (152)

Page 1 of 4
DeviceModel / ReferenceRegistriesClassStatus
AlereTM 92217
FDA UDI
Class IIActive
Alere Cholestech LDX® 14875
FDA UDI
Class IUnknown
SureStep™ Urine Test Drug Screen Strip DCO-101
FDA UDI
Class IIActive
Alere Cholestech LDX® 10-987
FDA UDI
Class IUnknown
SureStep™ Urine Test E-Z Split Key™ Drug Screen Cup DBO-187-011
FDA UDI
Class IIActive
CERTUM OPI One Step Opiate Test Strip DOP-101-a-Sgl
FDA UDI
Class IIActive
Clearview® 92401
FDA UDI
Class IIUnknown
CERTUM One Step Multi-Drug Screen Panel DOA-164-141-a
FDA UDI
Class IIActive
Alere Cholestech LDX® 88769
FDA UDI
Class IUnknown
CERTUM AMP One Step Amphetamine Test Strip DAM-101-a-Sgl
FDA UDI
Class IIActive
SureStep™ Urine Test Drug Screen Strip DMT-101
FDA UDI
Class IIActive
Alere Triage® 98201
FDA UDI
Class IUnknown
Clearview® 92002
FDA UDI
Class IActive
SureStepTM Urine Test Drug Screen Strip, Methamphetamine (MET 1000) DME-101-a-Sgl
FDA UDI
Class IIActive
SureStepTM Urine Test Drug Screen Strip, Cocaine (COC 300) DCO-101-a-Sgl
FDA UDI
Class IIActive
Alere Cholestech LDX® 99021
FDA UDI
Class IIActive
CERTUM One Step Multi-Line Drug Screen EZ Split DBO-167-301-a
FDA UDI
Class IIActive
CERTUM One Step Multi-Line Drug Screen EZ Split DBO-1107-401-a
FDA UDI
Class IIActive
SureStep™ Urine Test E-Z Split Key™ Drug Screen Cup DBO-177-161
FDA UDI
Class IIActive
SureStepTM Urine Test Drug Screen Strip, Methamphetamine (MET 500) DME-U101-a-Sgl
FDA UDI
Class IIActive
SureStepTM Urine Test Drug Screen Strip, Phencyclidine (PCP 25) DPC-101-a-Sgl
FDA UDI
UActive
Alere Triage® 98100EU
FDA UDI
Class IIUnknown
Alere Triage® 97000HS
FDA UDI
Class IIUnknown
SureStep™ Urine Test E-Z Split Key™ Drug Screen Cup DBO-1107-401
FDA UDI
Class IIActive
SureStep™ Urine Test Drug Screen Strip DBZ-101
FDA UDI
Class IIActive
SureStepTM Urine Test Drug Screen Strip, Barbiturates (BAR 300) DBA-101-a-Sgl
FDA UDI
Class IIActive
Alere Triage® 98000XR
FDA UDI
Class IIUnknown
SureStep™ Urine Test Drug Screen Cassette, Benzodiazepines (BZO 300) DBZ-102a
FDA UDI
Class IIActive
CERTUM AMP One Step Amphetamine Test Strip DAM-A101-a-Sgl
FDA UDI
Class IIActive
SureStep™ Urine Test E-Z Split Key™ Drug Screen Cup DBO-137-071
FDA UDI
Class IIActive
SureStepTM Urine Test Drug Screen Strip, Cocaine (COC 150) DCO-U101-a-Sgl
FDA UDI
Class IIActive
SureStep™ Urine Test E-Z Split Key™ Drug Screen Cup DBD-1107-092
FDA UDI
Class IIActive
Cholestech LDX™ 88773
FDA UDI
Class IActive
SureStepTM Urine Test Drug Screen Strip, Benzodiazepines (BZO 300) DBZ-101-a-Sgl
FDA UDI
Class IIActive
Alere Triage® 92000
FDA UDI
Class IIUnknown
Alere Cholestech LDX® 10-988
FDA UDI
Class IUnknown
Alere Triage® 97022HS
FDA UDI
Class IIUnknown
Signify® 01P48-25
FDA UDI
Class IIActive
AlereTM 92211
FDA UDI
Class IIActive
Integrated E-Z Split Key Cup II DOA-157-062-19-ONW02B
FDA UDI
N/AActive
Alere Triage® 90008
FDA UDI
Class IIUnknown
SureStep™ Urine Test Drug Screen Strip DBA-101
FDA UDI
Class IIActive
SureStep™ Urine Test E-Z Split Key™ Drug Screen Cup DBO-167-022
FDA UDI
Class IIActive
SureStepTM Urine Test Drug Screen Strip, Marijuana (THC 50) DTH-101-a-Sgl
FDA UDI
Class IIActive
Clearview® 92405
FDA UDI
Class IUnknown
Cholestech LDX™ 14874
FDA UDI
Class IActive
Signify® 01P52-25
FDA UDI
Class IIActive
CERTUM COC One Step Cocaine Test Strip DCO-U101-a-Sgl
FDA UDI
Class IIActive
SureStepTM Urine Drug Test Cassette DTH-102a
FDA UDI
Class IIActive
SureStepTM Urine Test Drug Screen Strip, Methylenedioxymethamphetamine (MDMA 500 DMD-101-a-Sgl
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (59)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Mar 1, 2024Z-1702-2024—open, classified

There is a potential that the Cholestech LDX battery (an external battery pack available as an optional accessory to the Cholestech LDX Analyzer) may swell which could cause minor burns, cuts or abrasions, or low current electrical shock to the user.

Jun 24, 2022Z-1508-2022—open, classified

Cholesterol test cassettes package insert is to be updated with new bilirubin interference information because it was found that samples containing bilirubin, at concentrations greater than 2.0 mg/dL (conjugated) or 1.6 mg/dL (unconjugated), can result in low recovery of Triglyceride (TRG) and High-Density Lipoproteins (HDL).

Feb 15, 2019Z-2475-2019—terminated

The polarity of the output of power supply was reversed. Due to polarity of the output of power supplies being reversed, it renders the power supplies nonfunctional and the analyzer inoperable.

Nov 14, 2017Z-0418-2018—completed

The recalled lots have demonstrated unexpected false positive THC results.

Oct 12, 2016Z-0588-2017—terminated

Encoded with incorrect ranges that are not consistent with the ranges printed on the Expected Value Card.

Aug 2, 2016Z-2778-2016—terminated

Incorrect expiration date on the magnetic strip that does not match the labeled expiration date.

Jul 11, 2016Z-2355-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2354-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring System (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2361-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2356-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2360-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2362-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Test Strips. This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2357-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring Systems (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2359-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring System (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jul 11, 2016Z-2358-2016—terminated

Alere San Diego is initiating a voluntary recall for the Alere INRatio/INRatio2 PT/INR Monitoring System (Test Strips and Meters). This action is being initiated as a result of patients who had a therapeutic or near-therapeutic INR with the Alere INRatio/INRatio2 PT/INR Monitoring System but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Jun 22, 2016Z-2265-2016—terminated

The Positive Control information referencing human plasma as the antibody material described in the product labeling and packaging is incorrect.

Jun 22, 2016Z-2270-2016—terminated

The Positive Control information referencing human plasma as the antibody material described in the product labeling and packaging is incorrect.

Jun 22, 2016Z-2267-2016—terminated

The Positive Control information referencing human plasma as the antibody material described in the product labeling and packaging is incorrect.

Jun 22, 2016Z-2271-2016—terminated

The Positive Control information referencing human plasma as the antibody material described in the product labeling and packaging is incorrect.

Jun 22, 2016Z-2268-2016—terminated

The Positive Control information referencing human plasma as the antibody material described in the product labeling and packaging is incorrect.

Jun 22, 2016Z-2269-2016—terminated

The Positive Control information referencing human plasma as the antibody material described in the product labeling and packaging is incorrect.

Jun 22, 2016Z-2266-2016—terminated

The Positive Control information referencing human plasma as the antibody material described in the product labeling and packaging is incorrect.

Aug 27, 2015Z-0122-2016—terminated

Alere San Diego is recalling the Alere Cholestech LDX Multianalyte Control because the assigned control ranges for the Total Cholesterol (TC) and Triglyceride (TRG) analytes are incorrect.

Dec 5, 2014Z-0881-2015—terminated

In certain cases, an INRatio PT/INR Monitor system may provide an INR result that is significantly lower than a result obtained using a reference INR system (laboratory method). This issue can arise if the patient has certain medical conditions. It can also occur if the instructions in the labeling for performing the test are not followed.

Dec 5, 2014Z-0880-2015—terminated

In certain cases, an INRatio PT/INR Monitor system may provide an INR result that is significantly lower than a result obtained using a reference INR system (laboratory method). This issue can arise if the patient has certain medical conditions. It can also occur if the instructions in the labeling for performing the test are not followed.

Dec 5, 2014Z-0882-2015—terminated

In certain cases, an INRatio PT/INR Monitor system may provide an INR result that is significantly lower than a result obtained using a reference INR system (laboratory method). This issue can arise if the patient has certain medical conditions. It can also occur if the instructions in the labeling for performing the test are not followed.

May 30, 2014Z-1928-2014—terminated

Alere San Diego is recalling Alere Triage BNP Calibrators for the Beckman Coulter Access Family of Immunoassay Systems because the bottle labeled as Calibrator Level 5 actually contains Calibrator Level 4. This results in a calibration failure when attempting to calibrate using a calibrator kit which contains the affected Level 5 Calibrator.

May 2, 2014Z-1727-2014—terminated

Alere initiated this recall because a limited number of Alere Triage D-Dimer devices from PN 98100 Lot W53884B were incorrectly manufactured. As a result, when testing patient sample these affected devices will either generate an error code (e.g. E4 error), or they may generate an incorrect result.

Apr 16, 2014Z-1546-2014—terminated

Test Strips may report an inaccurately low INR result. Several patients had a therapeutic or near-therapeutic INR with the Alere INRatio2 PT/INR Professional Test Strip but a significantly higher INR (outside of therapeutic range) when performed by a central laboratory.

Mar 20, 2014Z-1540-2014—terminated

These lots may not recover within range when tested using certain commercially available controls.

Feb 5, 2014Z-1214-2014—terminated

Alere San Diego, Inc. is initiating a recall of the Alere Triage TOX Drug Screen, Catalog Number 94400, Lots W56013B and W56035B because Alere's investigation has shown that these lots have a frequency of false negative results for PCP (Phencyclidine) that is higher than the frequency shown in the package insert. If you have questions about previously reported results.

Oct 23, 2013Z-0379-2014—terminated

Alere initiated a recall of Cholestech LDX Lipid Profile-GLU test cassettes, Catalog Number 10-991, Lot # 320167, becuase an incorrect lot number was printed on the outer 10 pack kit box label. The incorrect Lot # number printed was 321067.

Sep 23, 2013Z-0053-2014—terminated

Alere San Diego, Inc. initiated a voluntary recall of Alere Triage TOX Drug Screen Control 1 (PN 94413, Lot C2681A) because the CODE CHIP that was provided with this lot causes the control to fail when run in the QC Sample Mode using Alere Triage TOX Drug Screeen products. The Alere Triage TOX Drug Screen test devices and patient results are not affected.

Jun 3, 2013Z-0653-2014—terminated

Alere initiated this recall of certain lots of the Oral Fluid Drug Screen Device because the sponge may become dislodged from the Saliva Collector handle prior to or during the oral fluid sample collection process. If the sponge becomes dislodged during the specimen collection process, the donor may inadvertently swallow the sponge which could present a choking risk.

Apr 16, 2013Z-1401-2013—terminated

The firm initiated recall of Alere" hCG Combo Cassette (20/10 mIU/mL) kit PN 92215, lots hCG1110133 and hCG1110135, because an investigation has indicated a portion of these Alere" hCG Combo Cassette (20/10 mIU/mL) PN 92215 kit lots were incorrectly packaged with the Alere" hCG Cassette (20 mIU/mL) PN 92210 Product Insert. The Alere" hCG Cassette (20 mIU/mL) Product Insert contains information for

Mar 6, 2013Z-1139-2013—terminated

The recall was initiated because Alere San Diego has an update for the Alere Cholestech LDX ALT AST cassette, and it has the potential for humidity changes to impact results for certain analytes on the Alere Cholestech LDX System.

Mar 6, 2013Z-1178-2013—terminated

The Alere Cholestech LDX hsCRP cassette (PN 12-807) may have increased imprecision relative to the performance data in the package insert, which may cause differences in quantitative results for hsCRP compared to a reference method or repeat testing on the same patient sample.

Feb 26, 2013Z-1148-2013—terminated

Alere San Diego is recalling the Clearview Mononucleosis Cassette because the positive control included in the rapid test may produce false negative results.

Jan 21, 2013Z-1344-2013—terminated

Alere San Diego Inc. is recalling the Cardinal Health hCG Cassette Rapid Test because some of them were incorrectly packaged into Cardinal Health hCG Combo Rapid test kit boxes. The kit box incorrectly indicates the product may be used for both urine and serum sample types.

Oct 22, 2012Z-0746-2013—terminated

Out of range (increased) HDL Cholesterol results.

Oct 22, 2012Z-0747-2013—terminated

Out of range (increased) HDL Cholesterol results.

Jul 12, 2012Z-2460-2012—terminated

Alere San Diego is recalling Alere Triage TOX Drug Screen because there is a possibility that after installing the code chip provided with the affected lots: AMP, BAR, and PCP, the threshold ranges may not be consistently set correctly in all meters.

May 22, 2012Z-1931-2012—terminated

Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false positive and false negative results are unpredictable within lots and may not be detected by Quality Control testing.

May 22, 2012Z-1928-2012—terminated

Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false positive and false negative results are unpredictable within lots and may not be detected by Quality Control testing.

May 22, 2012Z-1930-2012—terminated

Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false positive and false negative results are unpredictable within lots and may not be detected by Quality Control testing.

May 22, 2012Z-1932-2012—terminated

Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false positive and false negative results are unpredictable within lots and may not be detected by Quality Control testing.

May 22, 2012Z-1929-2012—terminated

Certain lots of the affected products may have significantly decreased precision relative to the package insert, which could result in an increased frequency of false positive or false negative results. These false positive and false negative results are unpredictable within lots and may not be detected by Quality Control testing.

May 14, 2012Z-2039-2012—terminated

A recall was initiated because Alere San Diego has confirmed that the Triage TOX Drug Screen may have significantly decreased precision and accuracy than claimed. An increased frequency of false positive and/or false negative results has been observed for Triage TOX Drug Screen.

Mar 5, 2012Z-1467-2012—terminated

Alere San Diego, Inc. is initiating a voluntary recall of the Alere Triage CardioProfiler Panel PN 9700CP, Lot W49569 and the Alere Triage Profiler SOB Panel PN 97300, Lot W48990. Alere San Diego, Inc. has determined that these lots have an increased frequency of Troponin I results >0.05ng/mL for samples which are found to be below 0.05ng/mL upon additional testing.

Mar 5, 2012Z-1466-2012—terminated

Alere San Diego, Inc. is initiating a voluntary recall of the Alere Triage CardioProfiler Panel PN 9700CP, Lot W49569 and the Alere Triage Profiler SOB Panel PN 97300, Lot W48990. Alere San Diego, Inc. has determined that these lots have an increased frequency of Troponin I results >0.05ng/mL for samples which are found to be below 0.05ng/mL upon additional testing.

Jan 4, 2012Z-1130-2012—terminated

Alere San Diego received a rise in customer complaints regarding false positive Barbiturates (BAR) results on the Triage Drugs of Abuse Panel Plus TCA.

Oct 11, 2011Z-0188-2012—terminated

Alere has initiated a recall of the Professional Disposables International (PDI) alcohol prep products due to the potential presence of low levels of the microorganism Bacillus cereus.

Sep 1, 2011Z-1075-2012—terminated

Alere San Diego is expanding the scope of the voluntary recall of the Strep A Rapid Test Cassette and Twist devices from the single lot that was recalled in January 12, 2011 to all lots of product that were on the market within the expiry period.

Sep 1, 2011Z-1074-2012—terminated

Alere San Diego is expanding the scope of the voluntary recall of the Strep A Rapid Test Cassette and Twist devices from the single lot that was recalled in January 12, 2011 to all lots of product that were on the market within the expiry period.

Jul 1, 2011Z-0521-2012—terminated

The recall was initiated because Alere San Diego has confirmed false positive THC results obtained on Triage Drugs of Abuse Plus TCA 25 devices from lots 235991 and 238928.

Jun 10, 2011Z-2881-2011—terminated

Alere is initiating a voluntary recall on the listed lots of MULTI-DRUG 9 PANEL INTEGRATED CUP manufactured by Alere for sole use by Calloway Labs due to a mistake that occurred while processing the order, these products were incorrectly labeled as CLIA Waived, when in fact the devices are classified as Moderately Complex. Therefore these devices are misbranded.

Feb 28, 2011Z-2661-2011—terminated

The recall of the Triad Group alcohol prep products is due to potential contamination of these products with the bacteria Bacillus cereus, which could lead to life-threatening infections.

Nov 16, 2010Z-0964-2012—terminated

Alere has identified that a bias on results for certain analytes tested on the Alere Cholestech LDX System may exist due to humidity variability.

May 28, 2009Z-0029-2013—terminated

Biosite is recalling the Triage TOX Drug Screen kits where the box containing test devices because it was mislabeled.